On August 5, Wang Jiangping, Deputy Minister of the Ministry of Industry and Information Technology of China News Service, introduced on the 5th that as of the end of July, China’s daily nucleic acid testing capacity reached 4.84 million, with 4946 medical institutions capable of nucleic acid testing and 3.8 testing technicians. More than ten thousand people.
On August 1, all residents in the second building of Chuxing Greentown, Shuanghe City, Division City, Fifth Division of Xinjiang Corps were performing nucleic acid tests at the sampling points downstairs. Image source: People's Vision
The State Council Information Office held a regular policy briefing of the State Council on August 5. Wang Jiangping, Vice Minister of the Ministry of Industry and Information Technology, and relevant persons in charge of the Ministry of Science and Technology, the Health and Health Commission, and the National Food and Drug Administration introduced the situation regarding the improvement of new crown virus detection capabilities and answered reporters ask.
Wang Jiangping introduced that since the outbreak of the epidemic, the Ministry of Industry and Information Technology has established working mechanisms with relevant departments to guide and support scientific research institutions and manufacturers to actively carry out research and development of testing technologies, expand the production of testing reagents and equipment, and promote medical institutions to continuously improve nucleic acid testing. The ability basically meets the needs of domestic epidemic prevention and control.
As of the end of July, my country's daily nucleic acid testing capacity has reached 4.84 million, with 4946 medical institutions capable of nucleic acid testing and more than 38,000 testing technicians. A total of nearly 200 million copies of reagents and more than 12,000 sets of equipment have been sent to hospitals, disease control centers, customs ports, and third-party testing agencies across the country. Guaranteed the completion of the Wuhan conference where 10 million people were tested, the Beijing battle where 10 million people were tested, the normalized battles of foreign defense input from Heilongjiang, Guangdong, and Shanghai, and the emergency assault battles for recent clustered epidemic detection in Xinjiang and Dalian. Realize the "should be inspected" and "willing to inspect all".
Wang Jiangping introduced that in the next step, the Ministry of Industry and Information Technology will focus on four tasks in accordance with the deployment of the executive meeting of the State Council.
One is to promote the construction of testing capabilities. Under the premise of strengthening the prevention of biological safety risks, ensure that the national tertiary general hospitals, infectious disease hospitals, disease control institutions at all levels, and 1 county-level hospital in the county have nucleic acid detection capabilities before autumn and winter. At the same time, we will coordinate all aspects and strengthen the construction of mobile detection capabilities to ensure that they can be quickly dispatched in the early stages of the outbreak and cooperate with local detection forces to complete the detection tasks as soon as possible.
The second is to step up the training of testing personnel. The national and provincial CDCs, clinical testing centers, etc. organize nucleic acid testing technology training to meet the ever-increasing demand for testing capacity building.
The third is to strengthen scientific research and review and registration. Speed up the development of various new detection technologies and new products, especially products with short detection time, high sensitivity, and easy operation, to improve detection accuracy and efficiency. Promote the research and development of antigen detection and other new technologies and products, and further enrich the technical means of detection and screening. At the same time, it is necessary to strengthen early intervention in review and registration, promote more new products to enter the emergency approval channel, and minimize the time to market for products.
The fourth is to strengthen the production guarantee of testing reagents and equipment. Help enterprises to stabilize production and expand production, guide enterprises to continuously optimize the supply chain structure, and continuously improve the performance of testing products. Further play the role of the medical supplies guarantee dispatch platform, and strengthen the docking between production and demand. According to the capacity building needs of medical institutions and customs systems, coordinate enterprises to organize production and ensure supply. All relevant parties should strengthen financial and financial support for R&D and production, so as to fully guarantee the enhancement of nucleic acid testing capabilities.